# Title

 Food and Drugs. PART 530â€”EXTRALABEL DRUG USE IN ANIMALS


# ID

 CFR-2018-title21-vol6.Pt. 530


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                  |
|:------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['within', 'more than', 'prior to', 'less than', 'after', 'greater', 'at least']                                                                                                                                        |
| Duration    | ['2.0 year', '60.0 day', '20.0 month', '90.0 day']                                                                                                                                                                      |
| Condition   | ['provided that', 'where', 'if', 'when', 'unless']                                                                                                                                                                      |
| Entities    | ['Scope', 'Clenbuterol', 'Such', 'Extralabel', 'Food', 'Veterinarian', 'Safe', 'Rockville, MD', 'Chloramphenicol', 'Diethylstilbestrol', 'Dimetridazole', 'Ipronidazole', 'Fluoroquinolones', 'Purpose', 'Advertising'] |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                                 |
|:--------------|:----------------------------------------------------------------------------------------------------------------------------------------|
| within        | on the lawful order of a licensed veterinarian within  the context of a valid veterinary-client-patient relationship.                   |
| at least      | of the animal(s) by the veterinarian to initiate at least a general or preliminary diagnosis of the medical                             |
| more than     | and its active ingredient, or if formulated from more than one ingredient, the established name of each ingredient;                     |
| greater       | required by Federal or State law, whichever is greater .                                                                                |
| within        | written or oral order of a licensed veterinarian within the context of a valid veterinarian-client-patient relationship; and            |
| within        | and result in the drug being deemed unsafe within  the meaning of section 512 of the act:                                               |
| more than     | name of the drug or, if formulated from more than one active ingredient, the established name of each                                   |
| within        | a pharmacist on the order of a veterinarian within  the practice of veterinary medicine.                                                |
| within        | is performed by a licensed pharmacist or veterinarian within the scope of a professional practice; (4) Adequate                         |
| within        | form and concentration, except where a veterinarian finds, within the context of a valid veterinarian-client-patient relationship, that |
| prior to      | used; (ii) Establish a substantially extended withdrawal period prior to marketing of milk, meat, eggs, or other edible                 |
| prior to      | used; (ii) Establish a substantially extended withdrawal period prior to marketing of milk, meat, eggs, or other edible                 |
| after         | drug in food-producing animals if the agency finds, after providing an opportunity for public comment, that: (1)                        |
| after         | extralabel use of a drug in food-producing animals. after                                                                               |
| less than     | comments; and (3) Provide a period of not less than  60 days for comments.                                                              |
| after         | order of prohibition will become effective 90 days after date of publication of the order unless FDA                                    |
| prior to      | FDA publishes a notice in the Federal Register prior to that date, that revokes the order of prohibition,                               |
| after         | use in animals, or may modify a prohibition. after                                                                                      |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.0 year   | (b) A veterinarian shall keep all required records for 2 years or as otherwise required by Federal or State law, whichever is greater.                                                                                                                                                                                                                                                                                                                                  |
| 90.0 day   | (b) After making a determination that the analytical method required under &#167;&#8201;530.22 has not been developed and submitted, or that such method cannot be established, or that an extralabel use in animals of a particular human drug or animal drug presents a risk to the public health, FDA will publish in the Federal Register, with a 90-day delayed effective date, an order of prohibition for an extralabel use of a drug in food-producing animals. |
| 60.0 day   | Such order shall state that an acceptable analytical method required under &#167;&#8201;530.22 has not been developed, submitted, and found to be acceptable by FDA; that such method cannot be established; or that the extralabel use in animals presents a risk to the public health; and shall:                                                                                                                                                                     |
|            |               (1) Specify the nature and extent of the order of prohibition and the reasons for the prohibition;                                                                                                                                                                                                                                                                                                                                                        |
|            |               (2) Request public comments; and                                                                                                                                                                                                                                                                                                                                                                                                                          |
|            |               (3) Provide a period of not less than 60 days for comments.                                                                                                                                                                                                                                                                                                                                                                                               |
| 90.0 day   | (c) The order of prohibition will become effective 90 days after date of publication of the order unless FDA publishes a notice in the Federal Register prior to that date, that revokes the order of prohibition, modifies it, or extends the period of public comment.                                                                                                                                                                                                |
| 20.0 month | (12) Phenylbutazone in female dairy cattle 20 months of age or older.                                                                                                                                                                                                                                                                                                                                                                                                   |


## Condition

| Condition     | Context                                                                                                       |
|:--------------|:--------------------------------------------------------------------------------------------------------------|
| when          | Such use is limited to treatment modalities  when the health of an animal is threatened or                    |
| when          | Such a relationship can exist only  when the veterinarian has recently seen and is personally                 |
| where         | medically appropriate and timely visits to the premises where  the animal(s) are kept.                        |
| if            | of the drug and its active ingredient, or if formulated from more than one ingredient, the established        |
| if            | of the drug and its active ingredient, or if formulated from more than one ingredient, the established        |
| if            | labeling requirements of section 502(f) of the act if such use is: (a) By or on the                           |
| when          | or human drug by a lay person (except when  under the supervision of a licensed veterinarian);                |
| if            | (b) The established name of the drug or, if formulated from more than one active ingredient, the              |
| when          | new animal or approved new human drug that, when used as labeled or in conformity with criteria               |
| if            | use in food-producing animals will not be permitted if an approved animal drug can be used for                |
| where         | in the required dosage form and concentration, except where a veterinarian finds, within the context of a     |
| if            | or other edible products supported by appropriate scient if ic information,                                   |
| if            | an appropriate medical rationale; and (2) If scient if ic information on the human food safety aspect         |
| if            | food-producing animal is not permitted under this part if an animal drug approved for use in food-producing   |
| if            | drug or class of drugs in food-producing animals if FDA determines that: (1) An acceptable analytical method  |
| when          | human drug or an approved new animal drug when the agency finds that there is a reasonable                    |
| if            | concentration for that species or category of animals. if                                                     |
| if            | in food-producing animals has been established, the spec if ic safe levels, and the availability,             |
| if            | new animal or human drug in food-producing animals if the agency finds, after providing an opportunity for    |
| unless        | days after date of publication of the order unless FDA publishes a notice in the Federal Register             |
| where         | (b) of this section in exceptional circumstances (e.g., where there is immediate risk to the public health),  |
| provided that | there is immediate risk to the public health), provided that the order of prohibition states that the comment |
| if            | publishes a notice in the Federal Register mod if ying an order of prohibition, the agency will               |
| when          | drugs is permitted in nonfood-producing animal practice except when  the public health is threatened.         |
| if            | prohibiting such use following the procedures in &#167;&#8201;530.25. if                                      |
| if            | not approved for that species and production class. if                                                        |


## Entities

| Entities           | Context                                                                                                        |
|:-------------------|:---------------------------------------------------------------------------------------------------------------|
| Food               | Food  and Drugs.                                                                                               |
| Scope              | Scope .                                                                                                        |
| Purpose            | Purpose .                                                                                                      |
| Food               | on the lawful order of licensed veterinarians of Food and Drug Administration approved new animal drugs and    |
| Such               | Such use is limited to treatment modalities when the                                                           |
| Food               | Food  and Drug Administration.                                                                                 |
| Veterinarian       | (h)  Veterinarian means a person licensed by a State or                                                        |
| Advertising        | Advertising  and promotion.                                                                                    |
| Such               | Such information shall include the following: (a) The name                                                     |
| Extralabel         | Extralabel use from compounding of approved new animal and                                                     |
| Safe               | Safe  levels and analytical methods for food-producing animals.                                                |
| Rockville, MD      | Management, Center for Veterinary Medicine, 7500 Standish Pl., Rockville, MD  20855.                           |
| Such               | Such order shall state that an acceptable analytical method                                                    |
| Extralabel         | Extralabel  drug use in nonfood animals.                                                                       |
| Safe               | Safe  levels and availability of analytical methods.                                                           |
| Chloramphenicol    | (1)  Chloramphenicol ; (2) Clenbuterol; (3) Diethylstilbestrol (DES); (4) Dimetridazole;                       |
| Clenbuterol        | (1) Chloramphenicol;                                                                                           |
|                    |               (2)  Clenbuterol ; (3) Diethylstilbestrol (DES); (4) Dimetridazole; (5) Ipronidazole;            |
| Diethylstilbestrol | (1) Chloramphenicol;                                                                                           |
|                    |               (2) Clenbuterol;                                                                                 |
|                    |               (3)  Diethylstilbestrol (DES); (4) Dimetridazole; (5) Ipronidazole; (6) Other nitroimidazoles;   |
| Dimetridazole      | (1) Chloramphenicol;                                                                                           |
|                    |               (2) Clenbuterol;                                                                                 |
|                    |               (3) Diethylstilbestrol (DES);                                                                    |
|                    |               (4)  Dimetridazole ;                                                                             |
|                    |               (5) Ipronidazole;                                                                                |
|                    |               (6) Other nitroimidazoles;                                                                       |
|                    |               (7) Furazolidone.                                                                                |
| Ipronidazole       | (2) Clenbuterol; (3) Diethylstilbestrol (DES); (4) Dimetridazole; (5) Ipronidazole ;                           |
|                    |               (6) Other nitroimidazoles;                                                                       |
|                    |               (7) Furazolidone.                                                                                |
| Fluoroquinolones   | approved use of sulfadimethoxine, sulfabromomethazine, and sulfaethoxypyridazine); (10) Fluoroquinolones ; and |
|                    |               (11) Glycopeptides.                                                                              |


